RBF Capital’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

RBF Capital’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-63,857	Closed	-$47.6K	–	617
2024 Q4	$47.6K	Hold	63,857	–	–	﹤0.01%	538
2024 Q3	$77.9K	Sell	63,857 -2,400	-4%	-$3.82K	﹤0.01%	585
2024 Q2	$137K	Hold	66,257	–	–	0.01%	542
2024 Q1	$242K	Hold	66,257	–	–	0.01%	492
2023 Q4	$199K	Sell	66,257 -3,743	-5%	-$7.59K	0.01%	499
2023 Q3	$150K	Hold	70,000	–	–	0.01%	491
2023 Q2	$392K	Hold	70,000	–	–	0.02%	392
2023 Q1	$422K	Sell	70,000 -7,307	-9%	-$50.9K	0.03%	364
2022 Q4	$441K	Hold	77,307	–	–	0.03%	357
2022 Q3	$419K	Hold	77,307	–	–	0.04%	357
2022 Q2	$294K	Buy	+77,307	New	+$288K	0.02%	415

Other funds holding OMGA

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

RBF Capital's OMGA Position: Q1 2025 in Review

RBF Capital sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 63,857 shares — an estimated $47.6K sold.

RBF Capital first reported a position in OMGA in Q2 2022 and held it in 11 quarters. The position peaked at $441K in Q4 2022. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

RBF Capital reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
RBF Capital sold 63,857 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $47.6K.
RBF Capital first reported a position in Omega Therapeutics, Inc. Common Stock in Q2 2022 and held it in 11 quarters.
RBF Capital's Omega Therapeutics, Inc. Common Stock position peaked at $441K in Q4 2022.
4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on RBF Capital's 13F filing for Q1 2025, filed 15 May 2025.